CD274 and neoplasm: The authors proposed that in early-stage, resectable disease, high circulating PD-L1 may represent adaptive immune resistance against successful immune attack, whereas in advanced disease, elevated PD-L1 may reflect an overwhelming tumor burden and immune system failure.